Mean blood glucose responses (mmol/L) to an oral blood glucose bolus 2g/kg during a 120-minute period and mean area under the curve (mmol/L.min) during the oral blood glucose toler... by Elsie D. Oduor (22521785)

Mean blood glucose responses (mmol/L) to an oral blood glucose bolus 2g/kg during a 120-minute period and mean area under the curve (mmol/L.min) during the oral blood glucose toler... by Elsie D. Oduor (22521785)

Mean amplitude of the Slow Delta Envelope and period of Slow Delta oscillations in the disconnected hemisphere, compared with respect to wakefulness and NREM sleep in the reference... by Michele Angelo Colombo (22446342)

The results of mediating mechanism test. by Le Zhu (1771669)

Subjects:

Balance test results. by Le Zhu (1771669)

Subjects:

Variables. by Le Zhu (1771669)

Subjects:

Results of the parallel trend test. by Le Zhu (1771669)

Subjects:

Results of the exclusion of other policies. by Le Zhu (1771669)

Subjects:

Results of robustness tests. by Le Zhu (1771669)

Subjects:

Descriptive statistical of variables. by Le Zhu (1771669)

Subjects:

The results of Bootstrap Method and Sobel Test. by Le Zhu (1771669)

Subjects:

Impact of the NAMR on CSR dimensions (E, S, G). by Le Zhu (1771669)

Subjects:

Placebo test. by Le Zhu (1771669)

Subjects:

Baseline regression results. by Le Zhu (1771669)

Subjects:

Initial RBC dominant clot compaction in the <i>in vitro</i> MCA model without and with collateral with alteplase applied at clinically relevant concentration (1.3 mg L^-1... by Sandra Thalerová (11434762)

Change in influenza vaccination uptake from May 2020 to October 2024 (weighted). by Hannah Melchinger (20234665)

Subjects:

Results for fibrin dominant clots: (A) time to recanalize <i>in vitro</i> model; (B) relative clot reduction; (C) RBC release; (D) relative clot degradation rate. by Sandra Thalerová (11434762)

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the induction phase. by Elsie D. Oduor (22521785)

Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Line graph illustrating mean random blood glucose (mmol/L) at weekly intervals during the treatment phase. by Elsie D. Oduor (22521785)